XIFIN Partners with Translational Software to Provide Pharmacogenetic Testing Interpretation for Improved Health Outcomes

Business News
Print
SAN DIEGO--(BUSINESS WIRE)--XIFIN, Inc., the healthcare cloud computing company revolutionizing the business of healthcare diagnostics from patient to payment, today announced it has entered into an agreement with Translational Software®, a leader in integrating genetic information into routine clinical care, to market its end-to-end pharmacogenetic (PGx) knowledge solutions to support customers involved in PGx testing and personalized medicine initiatives. XIFIN will make Translational Softwar

imageimage
image

Read more